These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3499386)

  • 21. Analysis of the B cell subpopulations influenced by allogeneic effect factor. I. MHC restricted enhancement of b cell responses to thymic-independent antigens, types 1 and 2, in normal and CBA/N mice.
    Yaffe LJ; Mond JJ; Ahmed A; Scher I
    J Immunol; 1983 Feb; 130(2):632-6. PubMed ID: 6600248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential sensitivity to transforming growth factor (TGF)-beta of CBA and of CBA/N B cells demonstrates that the IgG2b inducing factor in synovial fluid from rheumatoid arthritis patients is not identical to TGF-beta.
    Ridderstad A; Lettesjö H; Abedi-Valugerdi M; Möller E
    Int Immunol; 1995 Mar; 7(3):459-69. PubMed ID: 7794824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoregulation in the Peyer's patch microenvironment. Cellular basis for the enhanced responses by the B cells of X-linked immunodeficient CBA/N mice.
    Eldridge JH; Beagley KW; McGhee JR
    J Immunol; 1987 Oct; 139(7):2255-62. PubMed ID: 2958543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect.
    Mosier DE; Mond JJ; Goldings EA
    J Immunol; 1977 Dec; 119(6):1874-8. PubMed ID: 334975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of a B-lymphocyte receptor for a T cell-replacing factor by the crosslinking of surface IgD.
    Yaffe LJ; Finkelman FD
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):293-7. PubMed ID: 6600516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of passive administration of alloantiserum containing antibody against putative acceptor(s) for T cell-replacing factor (TRF) in the neonatal stage on development of B cell activity responsive to TRF.
    Hashimoto Y; Tsukada S; Hamaoka T; Sano Y; Koyama N; Takatsu K
    Microbiol Immunol; 1986; 30(1):49-64. PubMed ID: 2939324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell replacing factor/interleukin 5 induces not only B-cell growth and differentiation, but also increased expression of interleukin 2 receptor on activated B-cells.
    Harada N; Matsumoto M; Koyama N; Shimizu A; Honjo T; Tominaga A; Takatsu K
    Immunol Lett; 1987 Jul; 15(3):205-15. PubMed ID: 3117678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody responses to thymic independent antigens in the peripheral and mesenteric lymph nodes of mice.
    Goud SN; Kaplan AM; Subbarao B
    Reg Immunol; 1990; 3(1):1-7. PubMed ID: 2121216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.
    Thompson CB; Scher I; Schaefer ME; Lindsten T; Finkelman FD; Mond JJ
    J Immunol; 1984 Nov; 133(5):2333-42. PubMed ID: 6207226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DBA/2J and DBA/2Ha lymphocytes differ in their ability to induce graft-vs-host disease.
    Fast LD
    J Immunol; 1989 Oct; 143(8):2489-93. PubMed ID: 2794505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two loci affecting B cell responses to B cell maturation factors.
    Sidman CL; Marshall JD; Beamer WG; Nadeau JH; Unanue ER
    J Exp Med; 1986 Jan; 163(1):116-28. PubMed ID: 3079812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice.
    Muul LM; Scher I; Mond JJ; Finkelman FD
    J Immunol; 1983 Nov; 131(5):2226-31. PubMed ID: 6605378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ia-restricted interaction between normal lymphoid cells and SJL lymphoma (RCS) leading to lymphokine production. I. Enhancement and suppression of antibody formation to TI antigens by supernatants and cells from cocultures of RCS and lymphoid cells.
    Hayama T; Nagler C; Umetsu DT; Chapman-Alexander J; Thorbecke GJ
    Cell Immunol; 1983 Jul; 79(1):134-49. PubMed ID: 6222793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active suppression of host-vs-graft reaction in pregnant mice. VII. Spontaneous abortion of allogeneic CBA/J x DBA/2 fetuses in the uterus of CBA/J mice correlates with deficient non-T suppressor cell activity.
    Clark DA; Chaput A; Tutton D
    J Immunol; 1986 Mar; 136(5):1668-75. PubMed ID: 2936806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Lyb-5 and Mls determinants by Peyer's patch B lymphocytes of X-linked immunodeficient mice.
    Eldridge JH; Yaffe LJ; Ryan JJ; Kiyono H; Scher I; McGhee JR
    J Immunol; 1984 Nov; 133(5):2308-11. PubMed ID: 6332843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective primary and secondary IgG responses to thymic-dependent antigens in autoimmune PN mice.
    Walker SE
    J Immunol; 1988 May; 140(10):3426-33. PubMed ID: 3283233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse.
    Klaus GG; Holman M; Johnson-Léger C; Elgueta-Karstegl C; Atkins C
    Eur J Immunol; 1997 Nov; 27(11):2749-56. PubMed ID: 9394795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative selection in vivo reveals expression of strong Mls determinants in mice with X-linked immunodeficiency.
    Webb SR; Mosier DE; Wilson DB; Sprent J
    J Exp Med; 1984 Jul; 160(1):108-15. PubMed ID: 6203996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Priming of peripheral lymph node B cells with TNP-Ficoll: role of lymphokines in B cell differentiation.
    Goud SN; Kaplan AM; Subbarao B
    Cell Immunol; 1992 Oct; 144(2):407-16. PubMed ID: 1394451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen-induced T cell-replacing factor (TRF). II. X-linked gene control for the expression of TRF-acceptor site(s) on B lymphocytes and preparation of specific antiserum to that acceptor.
    Tominaga A; Takatsu K; Hamaoka T
    J Immunol; 1980 May; 124(5):2423-9. PubMed ID: 6965972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.